Isolation and Characterization of Cell-Free DNA from Cerebral Organoids

Area of Science:

• Neuroscience
• Genetics
• Biomarker Discovery

Background:

• Early detection of neurological conditions is crucial for effective treatment.
• Invasive brain biopsies limit monitoring, necessitating alternative methods like analyzing bodily fluids.
• Cell-free DNA (cfDNA) in bodily fluids shows potential as a neurological biomarker, but its origin from brain tissue and response to neurological events are not fully understood.

Purpose of the Study:

• To investigate cell-free DNA (cfDNA) released from cerebral organoids.
• To assess the suitability of organoid-derived cfDNA for downstream molecular analyses.
• To explore potential associations between organoid cfDNA and neurological disorders.

Main Methods:

• Isolation and analysis of cfDNA from cerebral organoids.
• Quantification of cfDNA using droplet-digital PCR.
• Whole-genome sequencing of cfDNA fragments.
• Gene ontology analysis of genes associated with cfDNA fragments.

Main Results:

• Cerebral organoids release sufficient cfDNA for advanced analyses like droplet-digital PCR and whole-genome sequencing.
• Gene ontology analysis revealed terms related to neurodevelopment and autism spectrum disorder when examining genes linked to cfDNA fragments.
• This demonstrates a connection between organoid cfDNA and key neurological processes.

Conclusions:

• Cerebral organoids are a viable model for studying cfDNA release.
• Organoid-derived cfDNA can be analyzed using established molecular techniques.
• Cerebral organoids show promise as a tool for discovering novel cfDNA biomarkers for neurodevelopmental and neurological disorders.